Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 55

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment

Subramaniam, Courtney B., Bowen, Joanne M., Gladman, Marc A., Lustberg, Maryam B., Mayo, Samantha J., Wardill, Hannah R.·2020·Neuroscience & Biobehavioral Reviews
DOI 10.1016/j.neubiorev.2020.07.002
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neubiorev.2020.07.002

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 109

  1. Acharya, 2015, Stem cell transplantation reverses chemotherapy-induced cognitive dysfunction, Cancer Res., 75, 676, 10.1158/0008-5472.CAN-14-2237 · DOI
  2. Ahles, 2010, Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve, J. Clin. Oncol., 28, 4434, 10.1200/JCO.2009.27.0827 · DOI
  3. Amidi, 2017, Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy, J. Natl. Cancer Inst., 109, 10.1093/jnci/djx085 · DOI
  4. Anderson, 2017, A preliminary examination of gut microbiota, sleep, and cognitive flexibility in healthy older adults, Sleep Med., 38, 104, 10.1016/j.sleep.2017.07.018 · DOI
  5. Apple, 2017, Subtle hippocampal deformities in breast cancer survivors with reduced episodic memory and self-reported cognitive concerns, Neuroimage Clin., 14, 685, 10.1016/j.nicl.2017.03.004 · DOI
  6. Apple, 2018, Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy, Neuroimage Clin., 20, 110, 10.1016/j.nicl.2018.07.010 · DOI
  7. Aprile, 2008, Application of distance matrices to define associations between acute toxicities in colorectal cancer patients receiving chemotherapy, Cancer, 112, 284, 10.1002/cncr.23182 · DOI
  8. Bajaj, 2019, Post-traumatic stress disorder is associated with altered gut microbiota that modulates cognitive performance in veterans with cirrhosis, Am. J. Physiol. Gastrointest. Liver Physiol., 10.1152/ajpgi.00194.2019 · DOI
  9. Bajic, 2017, Neuroimmunological manifestations of chemotherapy exposure: implications for mucositis, Glia and cognition, J Can Sci Res, 2, 9
  10. Bajic, 2018, From the bottom-up: chemotherapy and gut-brain axis dysregulation, Front. Behav. Neurosci., 12, 104, 10.3389/fnbeh.2018.00104 · DOI · Paper page
  11. Banjara, 2017, Sterile neuroinflammation and strategies for therapeutic intervention, Int. J. Inflam., 2017, 8385961
  12. Barry, 2018, In vivo neuroimaging and behavioral correlates in a rat model of chemotherapy-induced cognitive dysfunction, Brain Imaging Behav., 12, 87, 10.1007/s11682-017-9674-2 · DOI
  13. Bisen-Hersh, 2013, Effects of early chemotherapeutic treatment on learning in adolescent mice: implications for cognitive impairment and remediation in childhood cancer survivors, Clin. Cancer Res., 19, 3008, 10.1158/1078-0432.CCR-12-3764 · DOI
  14. Branca, 2018, Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity, Oncotarget, 9, 23426, 10.18632/oncotarget.25193 · DOI
  15. Brandi, 2006, Intestinal microflora and digestive toxicity of irinotecan in mice, Clin. Cancer Res., 12, 1299, 10.1158/1078-0432.CCR-05-0750 · DOI
  16. Braniste, 2014, The gut microbiota influences blood-brain barrier permeability in mice, Sci. Transl. Med., 6, 263ra158, 10.1126/scitranslmed.3009759 · DOI · Paper page
  17. Callaghan, 2015, Long-term cognitive dysfunction in the rat following docetaxel treatment is ameliorated by the phosphodiesterase-4 inhibitor, rolipram, Behav. Brain Res., 290, 84, 10.1016/j.bbr.2015.04.044 · DOI
  18. Ceccarelli, 2017, Impact of high-dose multi-strain probiotic supplementation on neurocognitive performance and central nervous system immune activation of HIV-1 infected individuals, Nutrients, 9, 10.3390/nu9111269 · DOI
  19. Cerulla, 2017, Role of taxanes in chemotherapy-related cognitive impairment: a prospective longitudinal study, Breast Cancer Res. Treat., 164, 179, 10.1007/s10549-017-4240-6 · DOI
  20. Christie, 2012, Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy, Clin. Cancer Res., 18, 1954, 10.1158/1078-0432.CCR-11-2000 · DOI · Paper page
  21. de Ruiter, 2011, Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer, Hum. Brain Mapp., 32, 1206, 10.1002/hbm.21102 · DOI · Paper page
  22. de Souza-Talarico, 2011, Effects of stress hormones on the brain and cognition: evidence from normal to pathological aging, Dement. Neuropsychol., 5, 8, 10.1590/S1980-57642011DN05010003 · DOI
  23. Deprez, 2011, Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients, Hum. Brain Mapp., 32, 480, 10.1002/hbm.21033 · DOI · Paper page
  24. Dheen, 2007, Microglial activation and its implications in the brain diseases, Curr. Med. Chem., 14, 1189, 10.2174/092986707780597961 · DOI
  25. Dinan, 2017, The microbiome-gut-brain axis in health and disease, Gastroenterol. Clin. North Am., 46, 77, 10.1016/j.gtc.2016.09.007 · DOI · Paper page
  26. Distrutti, 2014, Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP, PLoS One, 9, e106503, 10.1371/journal.pone.0106503 · DOI · Paper page
  27. Dubois, 2014, Chemotherapy-induced long-term alteration of executive functions and hippocampal cell proliferation: role of glucose as adjuvant, Neuropharmacology, 79, 234, 10.1016/j.neuropharm.2013.11.012 · DOI
  28. El-Agamy, 2019, Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain, Cancer Chemother. Pharmacol., 10.1007/s00280-019-03827-0 · DOI
  29. ElBeltagy, 2010, Fluoxetine improves the memory deficits caused by the chemotherapy agent 5-fluorouracil, Behav. Brain Res., 208, 112, 10.1016/j.bbr.2009.11.017 · DOI
  30. Erny, 2015, Host microbiota constantly control maturation and function of microglia in the CNS, Nat. Neurosci., 18, 965, 10.1038/nn.4030 · DOI · Paper page
  31. Fardell, 2010, Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents, Pharmacol. Biochem. Behav., 97, 333, 10.1016/j.pbb.2010.08.019 · DOI
  32. Fardell, 2014, The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice, Psychopharmacology (Berl.), 231, 841, 10.1007/s00213-013-3301-8 · DOI
  33. Florian, 2016, Anti-microtubule drugs, Methods Mol. Biol., 1413, 403, 10.1007/978-1-4939-3542-0_25 · DOI
  34. Gangloff, 2005, Estimation of paclitaxel biodistribution and uptake in human-derived xenografts in vivo with (18)F-fluoropaclitaxel, J. Nucl. Med., 46, 1866
  35. Hall, 1992, Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignancies, Blood Rev., 6, 163, 10.1016/0268-960X(92)90028-O · DOI
  36. Holmes, 2013, Trying to unravel the mysteries of chemobrain, Lancet Neurol., 12, 533, 10.1016/S1474-4422(13)70087-5 · DOI
  37. Huehnchen, 2020, Cognitive impairment after cytotoxic chemotherapy, Neurooncol. Pract., 7, 11
  38. Hughes, 2019, The role of the gut microbiome in predicting response to diet and the development of precision nutrition models-part I: overview of current methods, Adv. Nutr.
  39. Janelsins, 2016, A clinically relevant dose of cyclophosphamide chemotherapy impairs memory performance on the delayed spatial alternation task that is sustained over time as mice age, Neurotoxicology, 56, 287, 10.1016/j.neuro.2016.06.013 · DOI
  40. Janelsins, 2017, Cognitive complaints in survivors of breast Cancer After chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study, J. Clin. Oncol., 35, 506, 10.1200/JCO.2016.68.5826 · DOI
  41. Johnstone, 2014, Understanding and improving platinum anticancer drugs--phenanthriplatin, Anticancer Res., 34, 471
  42. Jordan, 2018, Gut microbiota-immune-brain interactions in chemotherapy-associated behavioral comorbidities, Cancer, 124, 3990, 10.1002/cncr.31584 · DOI
  43. Keller, 2017, HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition, Mol. Psychiatry, 22, 527, 10.1038/mp.2016.120 · DOI · Paper page
  44. Kesler, 2016, Neurotoxic effects of anthracycline- vs nonanthracycline-based chemotherapy on cognition in breast Cancer survivors, JAMA Oncol., 2, 185, 10.1001/jamaoncol.2015.4333 · DOI
  45. Kesler, 2011, Prefrontal cortex and executive function impairments in primary breast cancer, Arch. Neurol., 68, 1447, 10.1001/archneurol.2011.245 · DOI
  46. Kirkley, 2017, Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity, J. Neuroinflammation, 14, 99, 10.1186/s12974-017-0871-0 · DOI
  47. Koppelmans, 2012, Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy, J. Clin. Oncol., 30, 1080, 10.1200/JCO.2011.37.0189 · DOI
  48. Kumagai, 2018, The microbiome and radiation induced-bowel injury: evidence for potential mechanistic role in disease pathogenesis, Nutrients, 10, 10.3390/nu10101405 · DOI
  49. Lange, 2017, How to identify and manage cognitive dysfunction after breast Cancer treatment, J. Oncol. Pract., 13, 784, 10.1200/JOP.2017.026286 · DOI
  50. Lengacher, 2015, Moderating effects of genetic polymorphisms on improvements in cognitive impairment in breast cancer survivors participating in a 6-Week mindfulness-based stress reduction program, Biol. Res. Nurs., 17, 393, 10.1177/1099800415577633 · DOI
  51. Ley, 2006, Ecological and evolutionary forces shaping microbial diversity in the human intestine, Cell, 124, 837, 10.1016/j.cell.2006.02.017 · DOI · Paper page
  52. Li, 2018, Investigation of chemotherapy-induced brain structural alterations in breast cancer patients with generalized q-sampling MRI and graph theoretical analysis, BMC Cancer, 18, 1211, 10.1186/s12885-018-5113-z · DOI
  53. Li, 2019, Gut microbiome and cancer immunotherapy, Cancer Lett., 447, 41, 10.1016/j.canlet.2019.01.015 · DOI · Paper page
  54. Liang, 2019, A comprehensive review of topoisomerase inhibitors as anticancer agents in the past decade, Eur. J. Med. Chem., 171, 129, 10.1016/j.ejmech.2019.03.034 · DOI
  55. Lim, 2016, PET evidence of the effect of donepezil on cognitive performance in an animal model of chemobrain, Biomed Res. Int., 2016, 6945415, 10.1155/2016/6945415 · DOI
  56. Lin, 2012, Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats, PLoS One, 7, e39764, 10.1371/journal.pone.0039764 · DOI
  57. Lively, 2018, Microglia responses to pro-inflammatory stimuli (LPS, IFNgamma+TNFalpha) and reprogramming by resolving cytokines (IL-4, IL-10), Front. Cell. Neurosci., 12, 215, 10.3389/fncel.2018.00215 · DOI
  58. Logan, 2007, The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs, Cancer Treat. Rev., 33, 448, 10.1016/j.ctrv.2007.03.001 · DOI
  59. Logan, 2008, Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs, Cancer Biol. Ther., 7, 1139, 10.4161/cbt.7.7.6207 · DOI
  60. Logan, 2008, Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis, Cancer Chemother. Pharmacol., 62, 33, 10.1007/s00280-007-0570-0 · DOI
  61. Loman, 2019, Chemotherapy-induced neuroinflammation is associated with disrupted colonic and bacterial homeostasis in female mice, Sci. Rep., 9, 16490, 10.1038/s41598-019-52893-0 · DOI
  62. Long-Smith, 2019, Microbiota-gut-Brain Axis: new therapeutic opportunities, Annu. Rev. Pharmacol. Toxicol.
  63. Lyons, 2011, Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy, Psychopharmacology (Berl.), 215, 105, 10.1007/s00213-010-2122-2 · DOI
  64. Manderino, 2017, Preliminary evidence for an association between the composition of the gut microbiome and cognitive function in neurologically healthy older adults, J. Int. Neuropsychol. Soc., 23, 700, 10.1017/S1355617717000492 · DOI · Paper page
  65. Martins-Teixeira, 2020, Antitumour anthracyclines: progress and perspectives, ChemMedChem, 10.1002/cmdc.202000131 · DOI
  66. McGinnis, 2017, Neuroinflammatory and cognitive consequences of combined radiation and immunotherapy in a novel preclinical model, Oncotarget, 8, 9155, 10.18632/oncotarget.13551 · DOI
  67. McVey Neufeld, 2013, The microbiome is essential for normal gut intrinsic primary afferent neuron excitability in the mouse, Neurogastroenterol. Motil., 25, 183, 10.1111/nmo.12049 · DOI · Paper page
  68. McVey Neufeld, 2015, The gut microbiome restores intrinsic and extrinsic nerve function in germ-free mice accompanied by changes in calbindin, Neurogastroenterol. Motil., 27, 627, 10.1111/nmo.12534 · DOI · Paper page
  69. Miura, 2018, Evaluation of the targeted delivery of 5-fluorouracil and ascorbic acid into the brain with ultrasound-responsive nanobubbles, J. Drug Target., 26, 684, 10.1080/1061186X.2017.1419354 · DOI
  70. Montassier, 2015, Chemotherapy-driven dysbiosis in the intestinal microbiome, Aliment. Pharmacol. Ther., 42, 515, 10.1111/apt.13302 · DOI
  71. Montassier, 2016, Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection, Genome Med., 8, 49, 10.1186/s13073-016-0301-4 · DOI
  72. Mu, 2015, Impairment of cognitive function by chemotherapy: association with the disruption of phase-locking and synchronization in anterior cingulate cortex, Mol. Brain, 8, 32, 10.1186/s13041-015-0125-y · DOI
  73. Nurgali, 2018, Editorial: adverse effects of Cancer chemotherapy: anything new to improve tolerance and reduce sequelae?, Front. Pharmacol., 9, 245, 10.3389/fphar.2018.00245 · DOI · Paper page
  74. Okubo, 2019, Impact of chemotherapy on the association between fear of cancer recurrence and the gut microbiota in breast cancer survivors, Brain Behav. Immun.
  75. Ouanes, 2019, High cortisol and the risk of dementia and alzheimer’s disease: a review of the literature, Front. Aging Neurosci., 11, 43, 10.3389/fnagi.2019.00043 · DOI · Paper page
  76. Palomo-Buitrago, 2019, Glutamate interactions with obesity, insulin resistance, cognition and gut microbiota composition, Acta Diabetol., 56, 569, 10.1007/s00592-019-01313-w · DOI
  77. Pedroso, 2015, Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice, Microbiology, 161, 1950, 10.1099/mic.0.000149 · DOI
  78. Peters, 2014, Novel developments in the use of antimetabolites, Nucleos. Nucleot. Nucl., 33, 358, 10.1080/15257770.2014.894197 · DOI
  79. Reininghaus, 2018, The impact of probiotic supplements on cognitive parameters in euthymic individuals with bipolar disorder: a pilot study, Neuropsychobiology, 1
  80. Ren, 2019, Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors, Biochim Biophys Acta Mol Basis Dis, 10.1016/j.bbadis.2019.02.007 · DOI
  81. Rochfort, 2014, Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions, PLoS One, 9, e101815, 10.1371/journal.pone.0101815 · DOI · Paper page
  82. Sarathy, 2017, The Yin and Yang of bile acid action on tight junctions in a model colonic epithelium, Physiol. Rep., 5, e13294, 10.14814/phy2.13294 · DOI · Paper page
  83. Sarkar, 2016, Psychobiotics and the manipulation of bacteria-gut-Brain signals, Trends Neurosci., 39, 763, 10.1016/j.tins.2016.09.002 · DOI · Paper page
  84. Savignac, 2015, Bifidobacteria modulate cognitive processes in an anxious mouse strain, Behav. Brain Res., 287, 59, 10.1016/j.bbr.2015.02.044 · DOI · Paper page
  85. Secombe, 2019, The bidirectional interaction of the gut microbiome and the innate immune system: implications for chemotherapy-induced gastrointestinal toxicity, Int. J. Cancer, 144, 2365, 10.1002/ijc.31836 · DOI
  86. Seigers, 2009, Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats, Behav. Brain Res., 201, 279, 10.1016/j.bbr.2009.02.025 · DOI
  87. Seigers, 2015, Cognitive impact of cytotoxic agents in mice, Psychopharmacology (Berl.), 232, 17, 10.1007/s00213-014-3636-9 · DOI
  88. Selamat, 2014, Chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications, PLoS One, 9, e108002, 10.1371/journal.pone.0108002 · DOI
  89. Shabani, 2012, Evaluation of destructive effects of exposure to cisplatin during developmental stage: no profound evidence for sex differences in impaired motor and memory performance, Int. J. Neurosci., 122, 439, 10.3109/00207454.2012.673515 · DOI
  90. Shabani, 2012, Profound destructive effects of adolescent exposure to vincristine accompanied with some sex differences in motor and memory performance, Can. J. Physiol. Pharmacol., 90, 379, 10.1139/y11-132 · DOI
  91. Silverman, 2007, Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy, Breast Cancer Res. Treat., 103, 303, 10.1007/s10549-006-9380-z · DOI
  92. Stringer, 2007, Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat, Exp. Biol. Med. (Maywood), 232, 96
  93. Stringer, 2008, Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats, Cancer Biol. Ther., 7, 1919, 10.4161/cbt.7.12.6940 · DOI
  94. Stringer, 2009, Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile, Int. J. Exp. Pathol., 90, 489, 10.1111/j.1365-2613.2009.00671.x · DOI
  95. Stringer, 2009, Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis, Exp. Biol. Med. (Maywood), 234, 430, 10.3181/0810-RM-301 · DOI
  96. Stringer, 2013, Biomarkers of chemotherapy-induced diarrhoea: a clinical study of intestinal microbiome alterations, inflammation and circulating matrix metalloproteinases, Support. Care Cancer, 21, 1843
  97. Suarez, 2018, Gut vagal sensory signaling regulates hippocampus function through multi-order pathways, Nat. Commun., 9, 2181, 10.1038/s41467-018-04639-1 · DOI
  98. Sudo, 2004, Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice, J. Physiol. (Paris), 558, 263
  99. Trubiano, 2016, Australasian society of Infectious diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand, Intern. Med. J., 46, 479, 10.1111/imj.13027 · DOI
  100. Wardill, 2017, Determining risk of severe gastrointestinal toxicity based on pretreatment gut microbial community in patients receiving cancer treatment: a new predictive strategy in the quest for personalized cancer medicine, Curr. Opin. Support. Palliat. Care, 11, 125, 10.1097/SPC.0000000000000265 · DOI
  101. Wardill, 2016, Cytokine-mediated blood brain barrier disruption as a conduit for cancer/chemotherapy-associated neurotoxicity and cognitive dysfunction, Int. J. Cancer, 139, 2635, 10.1002/ijc.30252 · DOI
  102. Wardill, 2016, Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-Dependent mechanisms, Mol. Cancer Ther., 15, 1376, 10.1158/1535-7163.MCT-15-0990 · DOI
  103. Wardill, 2019, Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients, EBioMedicine, 44, 730, 10.1016/j.ebiom.2019.03.070 · DOI
  104. Wigmore, 2013, The effect of systemic chemotherapy on neurogenesis, plasticity and memory, Curr. Top. Behav. Neurosci., 15, 211, 10.1007/7854_2012_235 · DOI · Paper page
  105. Wong, 2019, New approaches to microbiome-based therapies, mSystems, 4, 10.1128/mSystems.00122-19 · DOI
  106. Yang, 2010, Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits, Neurobiol. Learn. Mem., 93, 487, 10.1016/j.nlm.2010.01.006 · DOI
  107. Yang, 2011, Neurotoxicity of methotrexate to hippocampal cells in vivo and in vitro, Biochem. Pharmacol., 82, 72, 10.1016/j.bcp.2011.03.020 · DOI
  108. Zheng, 2020, A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae, Int. J. Syst. Evol. Microbiol.
  109. Zwielehner, 2011, Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting, PLoS One, 6, e28654, 10.1371/journal.pone.0028654 · DOI

Cited by

Metadata

Authors
Subramaniam, C. B., Bowen, J. M., Gladman, M. A., Lustberg, M. B., Mayo, S. J., & Wardill, H. R.
Venue
Neuroscience & Biobehavioral Reviews
Publisher
Elsevier BV
Published
2020-09
Volume
116
Pages
470-479
ISSN
0149-7634
DOI
10.1016/j.neubiorev.2020.07.002
Cited by
55
References
27
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • National Health and Medical Research Council
  • Australian Government

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.